USPTO serial 79303111
CUBIC-HV
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 20, 2022
- Examiner
- KUHN, RIO NICE
- Law office
- Historical data usage
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CUBIC-HV?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
JP
Kurume-shi Fukuoka, JP
Kurume-shi Fukuoka, JP
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Analytical chemical agents for analysis in laboratories other than for medical or veterinary purposes; colored reagents kit comprising staining probes, namely, dyes, antibodies, DNA and RNA probes and specialized staining buffers for preparation of histological specimens or histopathological specimens for microscopic evaluation, other than for medical or veterinary use; coloring kit for making histological specimen or pathological specimens for microscopic evaluation consisting of chemical reagents other than for medical or veterinary purpose; chemical reagents, other than for medical or veterinary use; chemical agents for histological and pathological assays for scientific purposes, other than for medical or veterinary use; diagnostic reagents, other than for medical or veterinary use; analytical chemical agents for histological and pathological assays in laboratories, other than for medical or veterinary use; diagnostic reagents and preparations, other than for medical or veterinary use; reagents for scientific devices for chemical and biological analysis purposes; reagents for chemical analysis purposes other than for medical or veterinary purposes; chemical agents for histological and pathological scientific purposes other than for medical or veterinary purposes; chemical reagents for scientific purposes other than for medical or veterinary purposes; cell culture reagents for scientific or research purposes; antibody reagents for scientific purposes; reagents for scientific purposes; reagents for scientific use; biochemical preparations for scientific purposes; reagents for scientific or research use; reagents for research purposes; chemical reagents for paternity testing; chemical agents for use in manufacture of pharmaceuticals; in vitro diagnostic agents for scientific purposes; biochemical catalysts; biological preparations, other than for medical or veterinary use; chemicals for product development by biotechnology; penetrants for enhancing penetration of staining probes, namely, dyes, antibodies and DNA and RNA probes; chemical agents for histological and pathological staining, increasing signal-noise ratio and enhancing staining probe penetration; chemicals, namely, mixture of HEPES buffer, Triton X-100, NaCl, casein and screened penetrants; chemical reagents for non-medical purposes; reagents for protein examination and detection purposes, other than for medical or veterinary use; blocking reagents for bioassay purposes, other than for medical or veterinary use; stabilizing reagents for bioassay purposes, other than for medical or veterinary use; reagents for genetic research purposes, other than for medical or veterinary use; reagents and reagent chemicals for chemistry and research purposes, other than for medical or veterinary use; chemical reagents for scientific, research, or experimental purposes, other than for medical or veterinary use; reagents for scientific, experimental, and research purposes, other than for medical or veterinary use; reagents for detection of nucleic acid mutation, other than for medical or veterinary use; reagents for examination of proteins in specimens, other than for medical or veterinary use; reagents for examination of specific bacteria in specimens, other than for medical or veterinary use; reagents for detection or quantification of cells or cytoplasm, other than for medical or veterinary use; biochemical reagents, other than for medical use; protein analysis reagents, other than for medical or veterinary use; chemical reagents consisting of antibody kit for detection of particular protein, other than for medical or veterinary use; labeling reagents, other than for medical or veterinary use; chemical reagents for protein isolation, detection, measurement, and analysis purposes other than for medical or veterinary purpose; chemical reagents for scientific use, other than for medical or veterinary purpose; chemical reagents consisting of antibodies, other than for medical or veterinary purpose; chemical reagents for diagnosis using molecular sequences of extracts or analytes from or of organisms or biological substances such as nucleic acids, proteins, polypeptides, and antibodies, other than for medical or veterinary purpose; chemical reagents selected for research in life science field; laboratory reagents for use in molecular biology; biochemical reagents for use in molecular biology; chemical reagents for use in molecular biology and life science; molecular biological reagents for research purposes; reagents for test, examination, and research of pharmaceuticals, cosmetics, laboratory animals, human pathology specimen, or foods, other than for medical or veterinary use; staining reagents for research purposes, other than for medical or veterinary use; reagents and staining chemicals for preparation of histopathological specimens for research use; reagents and staining * chemical * agents for preparation of histopathological specimen for research use; staining chemicals and reagents for tissue specimens on microscope slides other than for medical or veterinary purpose; staining * chemical * agents and reagents for tissue specimens on microscope slides other than for medical or veterinary purpose; reagents for research and scientific purposes in histological and pathological fields, other than for medical or veterinary use; chemical reagents, biological reagents, cell lines reagents, cultured cells reagents, cell culture reagents, diagnostic chemicals, diagnostic and biological reagents, diagnostic and biological pharmaceuticals, and recombinant and natural proteins for diagnostic, scientific, industrial, experimental, and research purposes, for use in chemical, pharmaceutical, biotechnological, and diagnostic fields, other than for medical or veterinary use; reagents for chemistry, biology, biochemistry, immunology, and microbiology, and chemical agents for nucleic acid synthesis and analysis, other than for medical or veterinary use; reagents for scientific, experimental, or medical research, other than for medical or veterinary use; reagents for academic studies, administrative research, scientific research, and medical science research, other than for medical or veterinary use; chemical reagents for detection and visualization of nucleic acids or antibodies of biologically-derived materials on microscope slides for research or scientific purposes, other than for medical or veterinary use; diagnostic reagents for scientific or research purposes in oncological field, other than for medical or veterinary use; diagnostic reagents and chemical reagents, other than for medical or veterinary use; chemical agents and chemical reagents for use in field of research and engineering relating to biology or genetics, and chemicals for use in science and research, other than for medical or veterinary use; reagents for staining tissues and cells for scientific and research use; analytical samples and reagents for drug development and life science research, other than for medical or veterinary use; chemicals and chemical agents for manufacture of medicines and reagents, namely, HEPES buffer, Triton X-100, NaCl, casein and screened penetrants; chemical agents and reagents for detection of cancer diseases, tumor diseases, inflammatory conditions, infectious diseases, degenerative conditions, genetic abnormalities or genetic diseases, proliferative abnormalities or proliferative diseases, vascular diseases, precancerous conditions, malignant diseases, cancers, and congenital abnormalities for scientific or research purposes, other than for medical or veterinary use; reagents for pathological research, other than for medical or veterinary use; immunostaining reagents, other than for medical or veterinary use; reagents for test, assay, analysis, research, experiment, examination, and detection of protein in physical chemistry or biology and somatology, other than for medical or veterinary use; reagents for test, assay, analysis, research, experiment, examination, and detection of RNA in physical chemistry or biology and somatology, other than for medical or veterinary use; reagents for test, assay, analysis, research, experiment, examination, and detection of nucleic acid in physical chemistry or biology and somatology, other than for medical or veterinary use; reagents for test, assay, analysis, research, experiment, examination, and detection of nucleic acid mutation in physical chemistry or biology and somatology, other than for medical or veterinary use; reagents for test, assay, analysis, research, experiment, examination, and detection of cells and cytoplasm in physical chemistry or biology and somatology, other than for medical or veterinary use; chemical agents for use in RNA stabilization before and after purification in physicochemical experiments and medical tests; chemical reagents for experimental or research purposes; reagents for preparation and staining of tissue samples for processing for research; histology and cytology reagents and staining chemicals for preparation of histopathological specimens for research purposes, other than for medical or veterinary use; histology and cytology reagents and staining liquid for preparation of histopathological specimen for research purposes, other than for medical or veterinary use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 11, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 3, 2024 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Jul 31, 2024 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Jul 30, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 28, 2023 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Dec 7, 2023 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Nov 23, 2023 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jul 3, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 13, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 13, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 25, 2023 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Mar 28, 2023 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Mar 23, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 23, 2023 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Mar 23, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 20, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 24, 2022 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Sep 20, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 20, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 18, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 5, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 5, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 5, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 29, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 29, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 15, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 15, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 15, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 31, 2022 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| May 27, 2022 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| May 25, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 25, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 25, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 25, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 25, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 28, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 28, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 28, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 27, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 27, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 27, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 8, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 16, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 16, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 29, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 28, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 26, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 2, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 29, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 28, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |